Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.7672
-0.0098 (-1.26%)
Aug 12, 2025, 11:56 AM - Market open
Cosmos Health Employees
Cosmos Health had 149 employees as of December 31, 2024. The number of employees increased by 26 or 21.14% compared to the previous year.
Employees
149
Change (1Y)
26
Growth (1Y)
21.14%
Revenue / Employee
$359,426
Profits / Employee
-$143,151
Market Cap
21.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 149 | 26 | 21.14% |
| Dec 31, 2023 | 123 | 21 | 20.59% |
| Dec 31, 2022 | 102 | 7 | 7.37% |
| Dec 31, 2021 | 95 | 6 | 6.74% |
| Dec 31, 2020 | 89 | 18 | 25.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COSM News
- 6 days ago - Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy - GlobeNewsWire
- 7 weeks ago - Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech - GlobeNewsWire
- 3 months ago - RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - GlobeNewsWire
- 3 months ago - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - GlobeNewsWire
- 3 months ago - Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units - GlobeNewsWire
- 3 months ago - Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq - GlobeNewsWire
- 3 months ago - Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 - GlobeNewsWire
- 4 months ago - Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million - GlobeNewsWire